iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026
The authorized capital increase creates additional unissued shares but does not itself increase shares outstanding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
iTonic Holdings (ITOC) will consolidate every 16 shares into one on October 6, 2026, subject to corporate requirements and Nasdaq not objecting. The consolidation covers Class A and Class B shares and takes effect at 12:01 a.m. Eastern Time. Class A shares are expected to begin split-adjusted trading that day.
Outstanding Class A shares will fall from 109,382,000 to approximately 6,836,375; Class B shares will fall from 7,668,000 to approximately 479,250. A related increase will raise authorized capital to US$800,000 without itself increasing outstanding shares. The company intends the consolidation to support regaining compliance with Nasdaq’s US$1.00 minimum bid price requirement by October 19, 2026; compliance is not assured.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- None.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.16-for-1 consolidation is intended to support regaining compliance with Nasdaq’s US$1.00 minimum bid price requirement.
- Minor pointOctober 19, 2026 compliance deadline remains; the consolidation does not assure regaining or maintaining Nasdaq compliance.
- Minor point. Forward-looking: it has not happened yet and may not happen.October 6 effectiveness is subject to applicable corporate requirements being completed and Nasdaq not objecting.
Details
Market move: ITOC -4.86% vs previous close. 16-for-1 share consolidation
On Oct 2, the day this news came out, the latest delayed price for ITOC is 4.86% below the previous close. Our momentum scanner has recorded 2 alerts for this stock so far that day. The latest delayed price is $0.27. Relative volume is exceptionally heavy at 15.3x the average.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Share consolidation ratio
- 16-for-1
- Class A and Class B ordinary shares
- Class A shares outstanding
- 109,382,000 to approximately 6,836,375 shares
- Before and after the consolidation
- Class B shares outstanding
- 7,668,000 to approximately 479,250 shares
- Before and after the consolidation
- Authorized share capital
- US$50,000 to US$800,000
- Authorized capital increase; does not itself increase shares outstanding
- Nasdaq minimum bid price
- US$1.00
- Nasdaq Listing Rule 5550(a)(2)
- Compliance deadline
- October 19, 2026
- Deadline to regain Nasdaq minimum bid-price compliance
- Effective date
- October 6, 2026
- Share consolidation, subject to applicable requirements and Nasdaq not objecting
Historical Context
-
Nasdaq granted an extension to regain the minimum bid-price requirement by October 19, 2026.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
par value financial
cusip number financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEIJING, China, Oct. 02, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (Nasdaq: ITOC) (the “Company”), a healthcare company developing digital medical technologies, today announced that at the extraordinary general meeting (the “EGM”) held on September 9, 2026, shareholders approved, among other matters, a 16-for-1 consolidation of the Company’s class A ordinary shares (the “Class A Ordinary Shares”) and class B ordinary shares (the “Class B Ordinary Shares”) (the “Share Consolidation”) and a related increase in authorized share capital. The Share Consolidation will combine every sixteen (16) issued and unissued Class A Ordinary Shares, par value US
The Share Consolidation will take effect at 12:01 a.m. Eastern Time on October 6, 2026 (the “Effective Date”), subject to completion of applicable corporate requirements and The Nasdaq Stock Market LLC (“Nasdaq”) not objecting. Upon the opening of the market on October 6, 2026, the Company’s Class A Ordinary Shares are expected to begin trading on The Nasdaq Capital Market on a post-Share Consolidation basis under the current symbol “ITOC”. The new CUSIP number for the Class A Ordinary Shares following the Share Consolidation will be G71399110, replacing the current CUSIP number G71399102.
The Share Consolidation will reduce the issued and outstanding Class A Ordinary Shares from 109,382,000 to approximately 6,836,375 and the issued and outstanding Class B Ordinary Shares from 7,668,000 to approximately 479,250. No fractional shares will be issued in connection with the Share Consolidation. Any fractional entitlement resulting from the Share Consolidation will be rounded up to the next whole Class A Ordinary Share or Class B Ordinary Share, as applicable.
Immediately following the Share Consolidation, the Company’s authorized share capital will remain US
Proportionate adjustments will be made, as applicable, to the number of shares issuable and the exercise or conversion prices under any outstanding options, warrants and convertible or exchangeable securities, and to share reserves under the Company’s equity incentive plans, in accordance with their respective terms.
The Share Consolidation is intended to increase the trading price per Class A Ordinary Share to support the Company’s efforts to regain compliance with the US
About iTonic Holdings Ltd
iTonic Holdings Ltd (Nasdaq: ITOC) is a technology-driven healthcare company focused on developing innovative digital medical solutions. Through strategic investments and technology partnerships, the Company seeks to advance healthcare transformation through artificial intelligence, automation and intelligent data platforms. For more information, please visit: http://www.ftzy.com.cn/ir/overview.php
Forward-Looking Statements
This press release contains forward-looking statements under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These include statements about the anticipated timing and implementation of the Share Consolidation, the Share Capital Increase and the amended and restated memorandum and articles of association; the number of shares outstanding after the Share Consolidation; post-consolidation trading and share prices; and the Company’s ability to regain or maintain compliance with Nasdaq’s listing requirements. Such statements reflect current expectations and assumptions and are subject to risks and uncertainties. Actual outcomes could differ materially because of delays in completing corporate or market implementation requirements, changes in the number of outstanding shares, market conditions, trading volatility, the Company’s financial and operating performance, and the risks described in the Company’s most recent annual report on Form 20-F and other SEC filings. Forward-looking statements speak only as of the date made. The Company undertakes no obligation to update them, except as required by law.
Investor Relations Contact
iTonic Holdings Ltd
Investor Relations
Email: ir@ftzy.com.cn
LLYC
Jackson Lin
Phone: +1-646-717-4593
Email: jian.lin@llyc.global
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How will iTonic’s consolidation affect options, warrants and convertible securities?
Proportionate adjustments will be made, as applicable, to shares issuable and exercise or conversion prices under outstanding options, warrants and convertible or exchangeable securities. Share reserves under equity incentive plans will also be adjusted, in accordance with their respective terms.